Wilsey Discloses $2.9 Million Purchase of Pfizer Stock Amid Landmark Trump Deal

Wilsey Asset Management disclosed the purchase of Pfizer shares valued at an estimated $2.9 million during the third quarter, according to an SEC filing released Wednesday.According to a filing with the Securities and Exchange Commission on Wednesday, Wilsey Asset Management bought an additional 118,248 shares of Pfizer (NYSE:PFE) during the third quarter. The estimated value of the trade, based on the average closing price for the period, was $2.9 million. The fund reported holding 1,103,543 shares at quarter-end, worth $28.1 million.The buy lifts Pfizer to 5.2% of Wilsey Asset Management’s 13F assets under management as of September 30.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool